Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2Other hematologic neoplasm 1

Conditions

Gastrointestinal Stromal Tumors 71Neoplasm Metastasis 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Stomach Neoplasms 4Sarcoma 4Pancreatic Neoplasms 4Neoplasms 3Digestive System Neoplasms 3Colorectal Neoplasms 3Colonic Neoplasms 3Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Piebaldism 2Myeloproliferative Disorders 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hodgkin Disease 2Gastrointestinal Neoplasms 2Blast Crisis 2Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Thrombocytosis 1Thrombocythemia, Essential 1Sezary Syndrome 1

Interventions

Imatinib Mesylate 2regorafenib 1nilotinib 1envafolimab 1Mastectomy, Segmental 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Piebaldism × Imatinib Mesylate × Gastrointestinal × Clear all
NCT05970900 2023-08-01

PIRKER

Fujian Medical University Union Hospital

Phase 3 Not yet recruiting
23 enrolled
GastrointestinalSarcoma

Piebaldism, Gastrointestinal Stromal Tumors

NCT00237185 2014-08-19

A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene

Novartis

Phase 2 Completed
148 enrolled 17 charts
GastrointestinalSarcoma

Piebaldism, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡